|
Per the clinic, the patient experienced an abutment loss and infection at the abutment site (specific date not reported).Subsequently, the patient was treated with oral antibiotics for fourteen days (specific date not reported) and topical antibiotics twice a day (specific date and duration not reported).The abutment was replaced on (b)(6) 2024.The internal fixture remains.
|
|
The reported adverse event is associated with a returned device; however, the provided clinical information was reviewed by the manufacturer and no specific device analysis is deemed necessary at this time.Previous product examinations have not showed any relationship between a product geometrical deviation and the reported clinical complication.Additionally, there are no indications that a product failure has contributed to the reported issue.Adverse skin reactions around the baha abutment, ranging from slight redness to infected tissue, are common complications with baha implants, and can occur at any time following implantation.The report frequency for these complications is being monitored under cbas complaint and medical device reporting data monitoring plan and the status is updated on a monthly basis.This event is added to this monitoring.
|